Sign in
WithdrawnNo phase

Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease

Key facts

Who runs it
Coordinación de Investigación en Salud, Mexico
Where
Mexico1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
15 Jul 2019
Ended
1 Apr 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Ablation of the gastroesophageal junction with hybrid argon plasma
  • mucosectomy with band of the gastroesophageal junction
Record updated
24 April 2025
Why it stopped
problems with participants enrollment

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Patients of both sexes over 18 years and under 90 years with a diagnosis of GERD and who are under medical treatment and who do not want surgical treatment
  • Confirmed diagnosis of GERD as follows:; Positive pHmetry. Positive endoscopy (Esophagitis grade C, D, stenosis or EB)
  • Esophagogastric junction Hill I-III
  • Total or partial response to proton pump inhibitors
  • Patient who does not wish to take medication for the treatment of gastroesophageal reflux in the long term or indefinitely or refractory GERD

Who cannot take part

  • Patients with major esophageal motility disorders
  • Patients with portal hypertension and presence of esophageal varices
  • Patients with hemophilia or some haematological disorder that is difficult to control
  • Patients with malignant pathology of the esophagus or Gastroesophageal Junction (GEJ)
  • Patients who do not accept the signature of the informed consent
  • Postoperative fundoplication patients for GERD
  • Patients with extraesophageal symptoms
  • Pregnant women
  • Patients with hiatal hernia larger than 3 cm or Hill type IV

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Gastroesophageal reflux disease has a high global prevalence, proton pump inhibitors are the cornerstone in the management but 10-20% of the patients are refractory to these, surgical treatment being an option of treatment in these patient but its associated with high morbidity, as well as a greater possibility of early therapeutic failure, for these reasons new therapies are in development being the mucosectomy with band and ablation of the esophagogastric junction with hybrid argon plasma options widely available that can offer a viable therapeutic option for patients with difficult control of symptoms or those who does not want to receive continuous medical treatment or surgical treatment. The aims of the study is to evaluate the safety and efficacy of this new techniques in the management or gastroesophageal reflux disease without hiatal hernia.

The 2 groups in the trial

  • Hybrid argon plasma.Existing treatment, for comparison

    After diagnostic endoscopy investigators will proceed to use argon plasma probe for marking 270 grades around the esophagogastric junction preserving part of the mucosa towards the greater curvature, then investigators will use the jet included in the argon plasma probe with effect 20 to 40 system for the injection of the background submucosa in the marking area, applying 0.9% saline solution with methylene blue, to achieve adequate Submucosal elevation for application or argon plasma with high voltages (100 watts, 1.5 liters / min) using forced coagulation mode, applying plasma argon to 1cm above the Z line in the esophageal mucosa and 2cm below it towards the gastric mucosa, argon will be applied until a "carbonization" effect of the mucosa is achieved, once the application of the therapy is performed mucosal lavage and immersion technique to corroborate integrity and continuity of the gastrointestinal tract and rule out immediate complications

    Treatment: Ablation of the gastroesophageal junction with hybrid argon plasma

  • Band mucosectomyExisting treatment, for comparison

    After diagnostic endoscopy investigators will proceed to use the tip of a polypectomy snare for marking 270 grades around the esophagogastric junction preserving part of the mucosa towards the greater curvature, then investigators will perform submucosal elevation with the injection of 0.9% saline with carmine indigo and adrenaline 1:10000, after adequate submucosal elevation investigators will proceed with the help of a band ligation cap to suction and release the elastic band in the previously marked and elevated tissue, proceeding to resect the previously ligated tissue with polypectomy loop below the elastic band with forced coagulation (Effect 2, 40 W), until the marked mucosa is completely resected (average used of 5 elastic bands, reviewing the work area for complications like bleeding or perforation.

    Treatment: mucosectomy with band of the gastroesophageal junction

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ablation Of The Esophagogastric Junction With Hybrid Argon Plasma Vs Mucosectomy With Band in Patients With Gastroesophageal Reflux Disease Without Hiatal Hernia
Record updated
24 April 2025